News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
foto_recurso_medicamentos
Alira Health Publishes a White Paper on the Impact of New European Union Regulations on Advanced Therapy Medicinal Product
Healthcare · Access to innovation · Drug discovery
It provides an overview of the key changes that will impact access to innovative medicines and…
células foto oryzon
ORYZON presents preliminary data from ongoing Phase Ib FRIDA trial with iadademstat plus gilteritinib in relapsed/refractory FLT3-mut AML patients at EHA-2024
Healthcare · Access to innovation · Drug discovery · Rare diseases
Data from the first two cohorts demonstrated that combination of iadademstat plus gilteritinib was…
Partners - Oryzon Genomics
Andrea Zapater, especialista en Producto Bio de Paralab Bio
#NewAseBioMember | “AseBio represents an essential platform for collaboration, networking and growth in the biotechnology sector”
Corporate
Meet Paralab Bio, our new member. We talked to its Andrea Zapater, Bio Product Specialist.
Partners - PARALAB
Rafael Simó
Rafael Simó: "We should talk about "obesities" instead of "obesity" because more and more phenotypes are described, in which genetic, metabolic, environmental, socio-cultural and mental health factors combine in different ways"
Healthcare · Access to innovation · Drug discovery
Geneis Biomed interviews Dr. Rafael Simón, head of the Endocrinology and Nutrition Department at…
Partners - GENESIS Biomed
Banner del Webinar de Pharmaron
Register for Webinar: Oligonucleotide Drugs: Key ADME & DMPK Insights
Healthcare
Pharmaron is holding a training webinar on June 20 on the importance of oligonucleotide drugs in…
Foto de un adulto anciano con un libro entre sus piernas y de un niño señalando el libro
Oryzon announces journal publication of final Phase IIa ALICE results with iadademstat in The Lancet Hematology
Healthcare · Access to innovation · Rare diseases · Innovative drugs · Advanced therapies
The Phase IIa study ALICE evaluated the combination of iadademstat plus azacitidine in newly…
Partners - Oryzon Genomics
Foto de la entrega del premio Nueva Empresa de Gipuzkoa 2024 a VIVEbiotech
VIVEbiotech receives the “New Company of Gipuzkoa 2024” award from ADEGI
Corporate
The award recognizes the success of companies less than 10 years old that create wealth and…
Partners - VIVEbiotech
Foto de una célula
Use of biotechnology in advanced therapies and new technologies in the spanish market
Healthcare · Access to innovation · Advanced therapies
Among the most important emerging technologies are the manipulation of the microbiota, CAR-T cell…
Partners - KONEXIO BIOTECH
edificio oryzon
Oryzon to provide corporate progress updates at several events in June
Healthcare · Corporate
BIO International Convention 2024. Congreso de la European Hematology Association (EHA) 2024.…
Partners - Oryzon Genomics